291 related articles for article (PubMed ID: 23910561)
21. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of FDG-PET in oncology.
Czernin J
Acta Med Austriaca; 2002; 29(5):162-70. PubMed ID: 12506767
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of positron emission tomography in sarcoma management.
Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review.
Annunziata S; Caldarella C; Treglia G
World J Radiol; 2014 Mar; 6(3):48-55. PubMed ID: 24765240
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
27. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
28. 18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies.
Gnanasegaran G; Agrawal K; Wan S
PET Clin; 2022 Jul; 17(3):369-388. PubMed ID: 35717098
[TBL] [Abstract][Full Text] [Related]
29. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
[TBL] [Abstract][Full Text] [Related]
30. [Present status of PET images: clinical FDG PET in oncology].
Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
[TBL] [Abstract][Full Text] [Related]
31. 18-Fluorodeoxyglucose imaging in oncology.
Harolds JA
J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography scanning: current and future applications.
Czernin J; Phelps ME
Annu Rev Med; 2002; 53():89-112. PubMed ID: 11818465
[TBL] [Abstract][Full Text] [Related]
33. PET imaging in oncology.
Bar-Shalom R; Valdivia AY; Blaufox MD
Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
[TBL] [Abstract][Full Text] [Related]
34. Cancer drug development using glucose metabolism radiopharmaceuticals.
Sun YY; Chen Y
Curr Pharm Des; 2009; 15(9):983-7. PubMed ID: 19275662
[TBL] [Abstract][Full Text] [Related]
35. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential.
Mercer JR
J Pharm Pharm Sci; 2007; 10(2):180-202. PubMed ID: 17706177
[TBL] [Abstract][Full Text] [Related]
36. The contribution of PET/CT to improved patient management.
Ell PJ
Br J Radiol; 2006 Jan; 79(937):32-6. PubMed ID: 16421402
[TBL] [Abstract][Full Text] [Related]
37. [PET and digestive cancers].
Talbot JN; Montravers F; Gutman F; Kerrou K; Huchet V; Grahek D; Andre T; Houry S; Touboul E; Rosmorduc O; Poupon R; Ruszniewski P; Rougier P; Grange JD
Presse Med; 2008 Feb; 37(2 Pt 2):e1-e24. PubMed ID: 17951024
[TBL] [Abstract][Full Text] [Related]
38. Developments in PET for the detection of endocrine tumours.
Eriksson B; Orlefors H; Oberg K; Sundin A; Bergström M; Långström B
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):311-24. PubMed ID: 15763703
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography.
Chin BB; Chang PP
Best Pract Res Clin Gastroenterol; 2006 Feb; 20(1):3-21. PubMed ID: 16473798
[TBL] [Abstract][Full Text] [Related]
40. [New functional imaging technique "positron emission tomography"].
Tamaki N
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
